logo

Therapeuticsmd (TXMD)



Trade TXMD now with
  Date
  Headline
5/31/2022 6:11:04 AM EW Healthcare Partners To Commence Tender Offer To Buy TXMD Common Stock For $10/Shr In All-cash Transaction
5/20/2022 9:48:01 AM TherapeuticsMD Receives FDA Approval For SNDA For ANNOVERA
3/10/2022 7:00:51 AM TherapeuticsMD Q4 Loss Per Share $0.10 Vs Loss $0.15 Last Year
12/8/2021 6:54:49 AM TherapeuticsMD Settles U.S. Patent Litigation With Amneal For BIJUVA
11/11/2021 6:58:42 AM TherapeuticsMD Q3 Net Loss $47.4 Mln Or $0.11/shr Vs Loss $32.6 Mln Or $0.12/shr Prior Year
11/11/2021 6:50:59 AM TherapeuticsMD Appoints Hugh O'Dowd As CEO
8/23/2021 6:55:26 AM TherapeuticsMD Announces Issuance Of A J-Code For ANNOVERA To Be Utilized In Public Health Sector
8/4/2021 6:59:21 AM TherapeuticsMD Q2 Net Loss $42.7 Mln Or $0.11/shr Vs. Loss $52.0 Mln Or $0.19/shr Prior Year
3/2/2021 7:19:27 AM TherapeuticsMD Q4 Loss Per Share $0.15 Vs Loss $0.19 Last Year